Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
4.34
+0.03 (0.69%)
Bozor ochiq: Aug 12, 2026, 12:56 PM EDT
4.05
-0.26 (-6.03%)
Oldingi bozordan keyin: Aug 11, 2026, 7:28 PM EDT
Adial Pharmaceuticals, Inc., klinik bosqichdagi biofarmatsevtika kompaniyasi, giyohvandlik va ular bilan bog'liq kasalliklarni davolash yoki oldini olish uchun terapevtik vositalarni ishlab chiqishga qaratilgan. Kompaniyaning asosiy mahsuloti AD04, serotonin-3 antagonistidir, u alkogol iste'mol qilish buzilishi uchun 3-bosqichli klinik sinovlarda. Shuningdek, kompaniya opioid bo'lmagan og'riqni kamaytirish va boshqa kasalliklar va buzilishlar uchun dori nomzodlarini ishlab chiqish bilan shug'ullanadi. Kompaniya 2010-yilda tashkil etilgan va Glen Allen, Virdjiniya shtatida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Julie Saiki Ph.D. | Executive Vice President of Strategy |
| Dr. Matthew Davidson Ph.D. | Chief Development Officer & Director |
| Mr. Abel Svitavsky CPA | Controller |
| Mr. Andrew Taubman | Vice President of Corporate Development |
| Mr. Cary John Claiborne MBA | CEO, President & Director |
| Mr. John R. Martin J.D. | Chief Legal Officer |
| Mr. Vinay Shah A.C.A., C.P.A., M.B.A. | CFO & Treasurer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-08-11 | 8-K/A | ea0299800-8ka1_adial.htm |
| 2026-06-11 | 8-K | ea0294448-8k_adial.htm |
| 2026-05-11 | 8-K | ea0289947-8k_adialpharma.htm |
| 2026-05-08 | 10-Q | ea0288762-10q_adial.htm |
| 2026-04-09 | 8-K | ea0285772-8k_adial.htm |
| 2026-03-06 | 8-K | ea0280282-8k_adial.htm |
| 2026-03-05 | 10-K | ea0279150-10k_adial.htm |
| 2026-03-03 | 8-K | ea0279472-8k_adial.htm |
| 2026-02-24 | 8-K | ea0278114-8k_adial.htm |
| 2026-02-04 | 8-K | ea0275033-8k_adial.htm |